KLI

Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)

Metadata Downloads
Publisher
BMC UROLOGY
Language
영어
ISSN
1471-2490
Citation Volume
20
Citation Number
1
Citation Start Page
181
Citation End Page
181
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.